[ Price : $8.95]
An FDA untitled letter to Eli Lilly cites the companys use of a promotional Web page for brain imaging drug Amyvid because it incl...[ Price : $8.95]
Janssen Research & Development refiles two supplemental NDAs for Xarelto following information requested by FDA in a 6/21 complete...[ Price : $8.95]
Celgene International plans to file an NDA early in 2013 for apremilast, indicated for treating patients with psoriatic arthritis.[ Price : $8.95]
FDA clears a Soligenix IND to begin Phase 1/2 studies of SGX203 for induction treatment of pediatric Crohns disease.[ Price : $8.95]
Impax says it has an agreement with Genzyme under which it will be licensed to produce generic forms of Renvela and Renagel in 201...[ Price : $8.95]
Amid rising criticism, FDA holds fast to its previously announced voluntary compliance approach to the use of human-use antibiotic...[ Price : $8.95]
FDA says it is extending past the 9/5 PDUFA deadline its review of a Salix NDA for crofelemer.[ Price : $8.95]
Fenwick & West attorney Michael Shuster sees the U.S. Supreme Court reviewing two conflicting federal circuit cases (Classen and M...